Literature DB >> 31659482

Non-convulsive status epilepticus in two patients with tuberous sclerosis.

Yuksel Erdal1, Alper Alnak2, Ozgur Oztop3, Pınar Tekturk4, Zuhal Yapici4.   

Abstract

Tuberous sclerosis (TSC) is an autosomal dominantly inherited genetic disorder that chiefly affects the central nervous system, along with the other multiple systems. While phenomenology and symptom severity may vary greatly from one individual to another, the most common neurological presentation is epilepsy, which may be refractory in a considerable number of patients. Convulsive SE is seen frequently in TSC patients due to the high ratio of refractory seizures in well-studied cohorts. Status epilepticus (SE) is a life-threating condition and requires urgent medical care. Non-convulsive status epilepticus (NCSE) is an epileptic state with no convulsive seizures but impaired consciousness and corresponding electrophysiological findings. Due to its heterogeneity of clinical features, it is generally hard to recognize, and thus difficult to treat promptly. The relationship between TSC and NCSE is a relatively less emphasized issue in the literature. Here, we present two cases of TSC with NCSE with a view to increasing clinicians' awareness of the association between refractory epilepsy and NCSE.

Entities:  

Keywords:  Non-convulsive status epilepticus; Status epilepticus; Tuberous sclerosis; mTOR inhibitors

Mesh:

Year:  2019        PMID: 31659482     DOI: 10.1007/s00381-019-04382-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

Review 1.  Nonconvulsive status epilepticus and continuous spike and slow wave of sleep in children.

Authors:  Cigdem Inan Akman
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

2.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 3.  Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.

Authors:  Paolo Curatolo; Rima Nabbout; Lieven Lagae; Eleonora Aronica; Josè Carlos Ferreira; Martha Feucht; Christoph Hertzberg; Anna C Jansen; Floor Jansen; Katarzyna Kotulska; Romina Moavero; Finbar O'Callaghan; Antigone Papavasiliou; Michal Tzadok; Sergiusz Jóźwiak
Journal:  Eur J Paediatr Neurol       Date:  2018-05-24       Impact factor: 3.140

Review 4.  Neurological and neuropsychiatric aspects of tuberous sclerosis complex.

Authors:  Paolo Curatolo; Romina Moavero; Petrus J de Vries
Journal:  Lancet Neurol       Date:  2015-07       Impact factor: 44.182

Review 5.  Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations.

Authors:  Paolo Curatolo; Sergiusz Jóźwiak; Rima Nabbout
Journal:  Eur J Paediatr Neurol       Date:  2012-06-12       Impact factor: 3.140

6.  Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma.

Authors:  Ichiro Kuki; Hisashi Kawawaki; Shin Okazaki; Eiji Ehara; Yoko Yoshida; Noritsugu Kunihiro; Yasuhiro Matsusaka
Journal:  Brain Dev       Date:  2018-02-02       Impact factor: 1.961

7.  Ictal signs in tuberous sclerosis complex: Clinical and video-EEG features in a large series of recorded seizures.

Authors:  Miriam Nella Savini; Alessia Mingarelli; Aglaia Vignoli; Francesca La Briola; Valentina Chiesa; Angela Peron; Roberto Mai; Laura Tassi; Massimo Mastrangelo; Elena Zambrelli; Katherine Turner; Maria Paola Canevini
Journal:  Epilepsy Behav       Date:  2018-06-12       Impact factor: 2.937

8.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.

Authors:  Jacqueline A French; John A Lawson; Zuhal Yapici; Hiroko Ikeda; Tilman Polster; Rima Nabbout; Paolo Curatolo; Petrus J de Vries; Dennis J Dlugos; Noah Berkowitz; Maurizio Voi; Severine Peyrard; Diana Pelov; David N Franz
Journal:  Lancet       Date:  2016-09-06       Impact factor: 79.321

9.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

10.  Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex.

Authors:  Hatem S Shehata; Hadeer Mahmoud AbdelGhaffar; Mohammed Nasreldin; Alaa Elmazny; Ahmed Abdelalim; Asmaa Sabbah; Nevin M Shalaby
Journal:  Ther Clin Risk Manag       Date:  2017-06-30       Impact factor: 2.423

View more
  1 in total

Review 1.  Non-Convulsive Status Epilepticus in the Presence of Catatonia: A Clinically Focused Review.

Authors:  Dax C Volle; Katharine G Marder; Andrew McKeon; John O Brooks; Jennifer L Kruse
Journal:  Gen Hosp Psychiatry       Date:  2020-11-13       Impact factor: 3.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.